INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/18/2025
Back to search
Official data from USPTO
GRAFTYS BIOINJECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GRAFTYS BIOINJECT
ST13
US500000079190948Class
5
Filing
79190948
Registration
5440314
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
12/19/2025
Trademark type
Word
Nice classes
5
Filing date
06/23/2016
Registration date
04/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/25/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
F-13290 Aix-en-Provence, FR
Examiner
SWIFT,GILBERT M
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GRAFTYS
Representatives
PROXIA-CONSEIL, SELARL
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of bone fractures; Chemical preparations for bone reconstruction and trauma surgery; Bone cements for bone reconstruction and surgery
Publications
History of USPTO decisions and trademark events.
37 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/26/2025
INPC
INVALIDATION PROCESSED
11/26/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/25/2025
C71T
CANCELLED SECTION 71
10/25/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/24/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/30/2018
FIMP
FINAL DISPOSITION PROCESSED
07/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/10/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/23/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/07/2018
PUBO
PUBLISHED FOR OPPOSITION
01/23/2018
GPNX
NOTIFICATION PROCESSED BY IB
01/19/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/03/2018
NPUB
NOTICE OF PUBLICATION
01/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/15/2017
CNEA
EXAMINERS AMENDMENT MAILED
12/14/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/14/2017
CNFR
FINAL REFUSAL MAILED
05/18/2017
CNFR
FINAL REFUSAL WRITTEN
05/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2017
ALIE
ASSIGNED TO LIE
04/13/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2017
RFNT
REFUSAL PROCESSED BY IB
10/21/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2016
RFRR
REFUSAL PROCESSED BY MPU
10/04/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/01/2016
CNRT
NON-FINAL ACTION WRITTEN
09/30/2016
DOCK
ASSIGNED TO EXAMINER
09/30/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/01/2016
Continuous trademark protection
Get notified about every new filing that threatens GRAFTYS BIOINJECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.